Nonmyeloablative stem cell transplants
- 1 November 1999
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Hematology
- Vol. 6 (6), 383
- https://doi.org/10.1097/00062752-199911000-00005
Abstract
Allogeneic stem cell transplantation (SCT) is a curative procedure in a number of hematologic malignancies, but its efficacy is limited by its toxicity, much of which is consequent upon the myeloablative conditioning regimens currently used. The recent demonstration that an immunologically mediated graft-versus-leukemia effect plays a central role in delivering the anti-leukemic effect of an allograft has led to a fundamental re-evaluation of the role of conditioning therapy in allogeneic transplantation. Recent animal studies have demonstrated that stem cell engraftment can occur using conditioning regimens that are minimally myelotoxic. This has prompted the development of less toxic nonmyeloablative conditioning protocols, the goal of which is to achieve donor stem cell engraftment allowing the graft-versus-tumor effect of the allograft to be exploited as the primary anti-leukemic strategy. Preliminary results using such nonmyeloablative clinical protocols confirm that durable engraftment of allogeneic stem cells can be achieved with a marked reduction in the immediate toxicity of transplantation. The extent to which this radically different transplant strategy allows the delivery of a sustained anti-leukemic effect is unclear at present, but it is likely that this approach will make an important contribution to allogeneic SCT in the future.Keywords
This publication has 27 references indexed in Scilit:
- Adhesion receptor expression by hematopoietic cell lines and murine progenitors: Modulation by cytokines and cell cycle statusExperimental Hematology, 1999
- Dependence of Human Stem Cell Engraftment and Repopulation of NOD/SCID Mice on CXCR4Science, 1999
- Stem cell homing: Rolling, crawling, and nestingProceedings of the National Academy of Sciences, 1998
- Endothelial selectins and vascular cell adhesion molecule-1 promote hematopoietic progenitor homing to bone marrowProceedings of the National Academy of Sciences, 1998
- Different Adhesive Characteristics and VLA-4 Expression of CD34+ Progenitors in G0/G1 Versus S+G2/M Phases of the Cell CycleBlood, 1998
- Role of Adhesion Molecules in the Homing and Mobilization of Murine Hematopoietic Stem and Progenitor CellsBlood, 1998
- The Fluctuating Phenotype of the Lymphohematopoietic Stem Cell with Cell Cycle TransitThe Journal of Experimental Medicine, 1998
- Lymphohematopoietic Engraftment in Minimally Myeloablated HostsBlood, 1998
- Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow TransplantationBone Marrow Transplantation, 1997
- The VLA4/VCAM-1 adhesion pathway defines contrasting mechanisms of lodgement of transplanted murine hemopoietic progenitors between bone marrow and spleen.Proceedings of the National Academy of Sciences, 1995